Roth Capital Partners is acting as the Company's financial advisor for this transaction.

Organovo is a clinical stage biotechnology company that is developing drugs that are demonstrated to be effective in three-dimensional (3D) human tissues as candidates for drug development. The ...

Akari Therapeutics Plc (Nasdaq: AKTX), a biotechnology company developing next-generation precision bi-functional antibody ...

Occidental announced an offer to exercise its outstanding publicly traded warrants at a temporarily reduced price. The Offer is available to ...

United Lithium Corp. (“United Lithium” or the “Company”) (CSE: ULTH; OTCQX: ULTHF; FWB: 0UL) is announcing that it has applied to ...

ASHKELON, ISRAEL and VANCOUVER, BRITISH COLUMBIA - February 28, 2025 (NEWMEDIAWIRE) - Femto Technologies Inc. (Nasdaq: FMTO) ...

SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA ...

SUNation Energy, Inc. (Nasdaq: SUNE), a leading provider of sustainable solar energy and backup power solutions for households, businesses, and municipalities ...

Oxbridge Re, together with its subsidiaries, has announced a $3.0 million registered direct offering and concurrent private ...

Two former Miami-Dade firefighters who face manslaughter and negligence charges in connection with the death of one of their ...

Two former Miami-Dade firefighters were booked into jail Friday morning on manslaughter and negligence charges in connection ...